Pressure BioSciences, Inc. Stock
Stocks
PBIO
US74112E2081
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
OTC Markets
13:43:58 2026-03-23 EDT
|
5-day change | 1st Jan Change | ||
| 0.000500 USD | -.--% |
|
-.--% | - |
| Market Cap | 143K 128K 118K 107K 201K 13.61M 204K 1.42M 564K 7.13M 538K 527K 22.48M | P/E 2022 |
-0.81x | P/E 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 20.49M 18.93M 17.16M 32.1M 2.18B 32.63M 228M 90.19M 1.14B 86.12M 84.29M 3.6B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Current month | +150.00% | ||
| 1 month | +150.00% | ||
| 3 months | -28.57% | ||
| 6 months | +150.00% |
| 1 month | 0 |  | 0 |
| Current year | 0 | | 0.1 |
| 1 year | 0 | | 0.2 |
| 3 years | 0 | | 0.8 |
| 5 years | 0 | | 2.74 |
| 10 years | 0 | | 11.52 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 2004-04-15 | |
| Chief Tech/Sci/R&D Officer | 61 | 2006-04-02 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 2006-04-23 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 1991-12-31 | |
Jeffrey Peterson
CHM | Chairman | 70 | 2012-08-07 |
Michael Urdea
BRD | Director/Board Member | 73 | 2013-02-07 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/27/24 | Others | Chief Executive Officer | 22,878 | 0.0659% | ||
| 9/27/24 | Others | Chairman | 59,652 | 0.1719% | ||
| 9/27/24 | Others | Chief Technology Officer | 18,863 | 0.0543% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | -98.74% | -99.93% | 21.48K | |
| -0.40% | -2.34% | +17.82% | +45.91% | 250B | |
| +0.33% | +0.64% | +3.49% | +12.96% | 162B | |
| +1.90% | +6.00% | -17.96% | +65.92% | 154B | |
| -0.70% | +2.93% | -55.38% | -8.86% | 66.68B | |
| +0.24% | +0.99% | -15.19% | -10.88% | 52.08B | |
| +0.15% | +4.09% | +10.82% | +65.55% | 52.22B | |
| -1.13% | +2.85% | +16.39% | +28.99% | 51.93B | |
| -0.47% | +0.06% | +17.37% | +58.29% | 49.02B | |
| -0.42% | +3.83% | +27.55% | +77.45% | 44.76B | |
| Average | -0.05% | +2.04% | -9.38% | +23.54% | 88.23B | |
| Weighted average by Cap. | +0.13% | +1.49% | +1.44% | +38.33% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.54M 1.43M 1.29M 2.42M 164M 2.46M 17.17M 6.8M 86.01M 6.49M 6.35M 271M | 1.98M 1.77M 1.63M 1.48M 2.77M 188M 2.81M 19.63M 7.77M 98.37M 7.42M 7.26M 310M |
| Net income | -16.08M -14.36M -13.26M -12.02M -22.49M -1.53B -22.86M -160M -63.19M -800M -60.33M -59.05M -2.52B | -29.31M -26.18M -24.18M -21.92M -41M -2.78B -41.68M -291M -115M -1.46B -110M -108M -4.6B |
| Net Debt | 20.53M 18.33M 16.93M 15.35M 28.71M 1.95B 29.18M 204M 80.67M 1.02B 77.03M 75.39M 3.22B | 22.8M 20.36M 18.81M 17.05M 31.9M 2.16B 32.42M 226M 89.63M 1.13B 85.58M 83.76M 3.58B |
Employees
16
- Stock Market
- Stocks
- PBIO Stock
Select your edition
All financial news and data tailored to specific country editions
